MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641058005 A) filed by Saveetha Institute Of Medical And Technical Sciences on May 07, 2026, for Controlled Release Of C-Glucoderm- Poly Spray For Enhanced Healing Of Diabetic Foot Ulcers.
Inventors include Dr. Chella Perumal Palanisamy; Dr. Gopalakrishnan Velliyur Kanniappan; Rukhsana Shahina Shahina; Dr. Rajkumar Thamarai; Dr. Kaliyamoorthy Dass; Dr. Venkatesan Karthick; Dr. Selvaraj Jayaraman; Dr. Nisha B; and Dr. Deepak Nallaswamy Veeraiyan.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention discloses a controlled-release polymeric spray formulation designated as C-GlucoDerm-Poly developed for topical management of diabetic foot ulcers. The formulation comprises an aqueous leaf extract of Psidium guajava incorporated into a chitosan—alginate polyelectrolyte complex along with pharmaceutically acceptable stabilizing and viscositymodifying agents. The ionic interaction between chitosan and alginate results in formation of a structured polymeric network capable of modulating release kinetics of plant-derived bioactive constituents. The formulation demonstrates sustained release behavior, antioxidant activity, antimicrobial efficacy against wound-associated pathogens, and cytocompatibility with mammalian skin cell lines under in vitro conditions. The spray delivery format ensures uniform application and supports maintenance of a moist wound environment. The invention provides a stable, scalable, and non-invasive therapeutic platform suitable for controlled- release diabetic foot ulcer management.
Disclaimer: Curated by HT Syndication.
